Ignite Creation Date:
2025-12-26 @ 5:22 PM
Ignite Modification Date:
2026-01-22 @ 8:28 AM
Study NCT ID:
NCT00706706
Status:
COMPLETED
Last Update Posted:
2013-01-18
First Post:
2008-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma
Sponsor:
Organization: